Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:TKNO

Alpha Teknova Q3 2026 Earnings Date & Estimates

Alpha Teknova logo
$6.59 +0.17 (+2.65%)
Closing price 04:00 PM Eastern
Extended Trading
$6.58 -0.01 (-0.23%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Teknova is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for November 4, 2026 at 6:00 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
6:00 PM ET

What Analysts Expect from Alpha Teknova in Q3 2026

Alpha Teknova is expected to post earnings of -$0.06 per share on revenue of $11.71 million. In the same quarter a year earlier Alpha Teknova reported -$0.08 per share on revenue of $10.45 million. Alpha Teknova last reported on August 5, 2026, posting -$0.06 per share and beating the -$0.0843 consensus estimate. Alpha Teknova has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.06
Expected Revenue
$11.71 million
Prior-Year EPS
-$0.08
Prior-Year Revenue
$10.45 million
Expected Revenue Growth
+12.0%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.06 (Beat by +$0.0243)
Last Quarter Revenue
$12.19 million
EPS Beat Rate
6 of last 8 quarters

Alpha Teknova Q3 2026 Earnings FAQ

Alpha Teknova (NASDAQ:TKNO) is estimated to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Alpha Teknova's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 6:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Alpha Teknova to post earnings of -$0.06 per share for Q3 2026.

The consensus revenue estimate for Alpha Teknova is $11.71 million for Q3 2026.

Alpha Teknova Earnings Headlines

Missed this in 2024? Here’s your second chance
In April 2024, gold had gone nowhere for 13 years - then it surged to a record high, more than doubling in value. Now gold has pulled back roughly 20%. Inflation is rising, the Fed is hiking rates, and government borrowing continues. Ross Givens says his long-term thesis still holds. He points to a backdoor gold play that ran 846%, 1,668%, and 1,915% in the last major cycle.tc pixel
Alpha Teknova stock tumbles on public offering announcement
See More Alpha Teknova Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alpha Teknova? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alpha Teknova and other key companies, straight to your email.

About Alpha Teknova

Alpha Teknova (NASDAQ:TKNO) is a life sciences company that develops and manufactures critical reagents and other products used in biomedical research, biopharmaceutical development and advanced therapies. The company provides laboratory and production materials designed to support applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development and pharmaceutical manufacturing.

Its offerings include research-use-only and current Good Manufacturing Practice (cGMP) reagents, buffers, media and other custom-formulated solutions. Alpha Teknova also provides custom manufacturing and development services, helping customers produce specialized liquid components and scale processes from research and development through commercial production.

Founded in 1996, Alpha Teknova is headquartered in Hollister, California, and serves life sciences customers in the United States and international markets. Its products are used by biotechnology and pharmaceutical companies, academic and research institutions, and diagnostic developers. The company trades on the Nasdaq under the symbol TKNO.

View Alpha Teknova Profile